Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Building a better sphingosine kinase-1 inhibitor.
Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort.
Receptos begins enrollment of Phase 3 trial of RPC1063 in relapsing multiple sclerosis
Multiple sclerosis and oligodendroglioma: an exceptional association.
Vitamin A and systemic inflammation as protective factors in multiple sclerosis.
Neuromyelitis Optica Following Human Papillomavirus Vaccination.
Magnetic Resonance Spectroscopy Markers of Disease Progression in Multiple Sclerosis.
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.
Fulminant Central Nervous System Nocardiosis in a Patient Treated With Alemtuzumab For Relapsing-Remitting Multiple Sclerosis.
DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
High levels of cerebrospinal fluid free kappa chains predict conversion to multiple sclerosis.
Structure and Activity of the Acid Sensing Ion Channels.
Subcellular distribution of FTY720 and FTY720-phosphate in immune cells - another aspect of Fingolimod action relevant for therapeutic application.
Disease-modifying therapies in Chinese children with multiple sclerosis.
Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis.
Twin studies and the heritability of MS: a conclusion.
Myelination of the nervous system: mechanisms and functions.
The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.
Clinical effects of natalizumab on multiple sclerosis appear early in treatment course.
The site of production of superoxide radical in mitochondrial Complex I is not a bound ubisemiquinone but presumably iron-sulfur cluster N2.
Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages.
Zebrafish screen identifies novel compound with selective toxicity against leukemia.
Current Immune Therapies of Autoimmune Disease of the Nervous System with Special Emphasis to Multiple Sclerosis.
Optic nerve disease and axon pathophysiology.
RORγt(+) cells selectively express redundant cation channels linked to the Golgi apparatus.

Pages